Opening of the new manufacturing plant
The architectural project started in 2017 with the aim of increasing the manufacturing capacity of Aliveda, always following the same values and company philosophy. The new plant (1000 sqm) has to fulfill the needs and requests of old and new clients. In these days, the plant is ready to start the production.Aliveda is now leader […]
Congresso 2016
Aliveda, with the patronage of the Italian Association of amyotrophic lateral sclerosis is delighted to invite to the conference “Amyotrophic lateral sclerosis: new mechanism of neurodegeneration for new therapies; development of a collaborative project”. The meeting will be on the 28th-29th October 2016 on the hills around Pisa, and it was thought as a moment […]
Microbiota e Salute Umana (Microbiota and human health): Aliveda matches with gastroenterologist and gynecologist on the role of intestinal microbiota on gut and vaginal health
The meeting “Microbiota e Salute Umana 2021” (Microbiota and human health) held at Grand Hotel Duomo in Pisa, on the 26th November 2021. The event, at its third edition, is a meeting occasion between doctors, interested in the human microbiota, and companies, to share their knowledge and to promote new collaborations and opportunities.Aliveda participates with […]
Hospital meeting: Aliveda presents its product Colicron to the gastroenterologist in Cisanello Hospital
On Tuesday 7th December, it held a meeting between Aliveda and Cisanello Hospital in Pisa, thanks to the arrangement with Prof. Dr. De Bortoli. During the meeting, Dr. Giulia Della Scala, representing the Medical Direction, Dr. Alessandro Toscano, CCO, and Dr. Nicoletta Grittani, medical and scientific informant in Pisa, had the chance to present to […]
Aliveda presents the new Chief Commercial Officer
Alessandro Toscano is the new Chief Commercial Officer for Aliveda. The partnership, born as consulting in 2020, during the pandemic, will be consolidate from January 2022, thanks to the brilliant results obtained, despite the health emergency worldwide. Dr. Toscano has previously worked in important pharmaceutical companies, such as Dompé, Merck, AstraZeneca and KRKA. “We are […]
Colicron in the clinical practice: the results of a clinical trial on patients with IBS-D
It was recently completed a clinical trial with 25 IBS-D patients involved, which allowed the evaluation of the efficacy of Colicron treatment in improving the symptoms and the clinical picture in these subjects.The trial expected the administration of Colicron for 8 weeks, 2 caps per day. At the beginning, after 4 weeks and then at […]
